FIKJX
Price
$16.81
Change
-$0.05 (-0.30%)
Updated
Jul 8 closing price
Net Assets
186.77M
VRTPX
Price
$21.44
Change
-$0.02 (-0.09%)
Updated
Jul 8 closing price
Net Assets
9.48B
Interact to see
Advertisement

FIKJX vs VRTPX

Header iconFIKJX vs VRTPX Comparison
Open Charts FIKJX vs VRTPXBanner chart's image
Fidelity Advisor Real Estate Z
Price$16.81
Change-$0.05 (-0.30%)
VolumeN/A
Net Assets186.77M
Vanguard Real Estate II Index
Price$21.44
Change-$0.02 (-0.09%)
VolumeN/A
Net Assets9.48B
FIKJX vs VRTPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FIKJX vs. VRTPX commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIKJX is a Buy and VRTPX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VRTPX has more cash in the bank: 9.48B vs. FIKJX (187M). VRTPX pays higher dividends than FIKJX: VRTPX (3.80) vs FIKJX (2.09). FIKJX was incepted earlier than VRTPX: FIKJX (7 years) vs VRTPX (8 years). FIKJX (0.62) is less costly to investors than VRTPX (0.08). FIKJX is a more actively managed with annual turnover of: 24.00 vs. VRTPX (4.00). FIKJX has a lower initial minimum investment than VRTPX: FIKJX (0) vs VRTPX (100000000). VRTPX annual gain was more profitable for investors over the last year : 10.62 vs. FIKJX (4.28). VRTPX return over 5 years is better than : 38.08 vs. FIKJX (-0.59).
FIKJXVRTPXFIKJX / VRTPX
Total Expense Ratio0.620.08775%
Annual Report Gross Expense Ratio0.620.08775%
Fund Existence7 years8 years-
Gain YTD1.4732.04972%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets187M9.48B2%
Annual Yield % from dividends2.093.8055%
Returns for 1 year4.2810.6240%
Returns for 3 years-13.169.42-140%
Returns for 5 years-0.5938.08-2%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LSSNX29.00N/A
N/A
Loomis Sayles Small Cap Growth N
PRHSX76.46N/A
N/A
T. Rowe Price Health Sciences
WPSGX56.24N/A
N/A
AB Concentrated Growth Advisor
IVKSX22.50N/A
N/A
VY® Invesco Comstock S
UAPIX62.18N/A
N/A
ProFunds UltraSmall Cap Inv